Cite

HARVARD Citation

    Søe, K. et al. (2014). Dosing related effects of zoledronic acid on bone markers and creatinine clearance in patients with multiple myeloma and metastatic breast cancer. Acta oncologica. pp. 547-556. [Online]. 
  
Back to record